Mergers and Acquisitions in the IVD Market
Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018.
Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott’s acquisition of Alere and related divestures and Danaher’s acquisition of Cepheid are among the specific deals discussed in the report.
The report also details acquisitions driven by the development of cutting-edge technologies such as gene editing, liquid biopsy, microbiome research, and next-generation sequencing.
Automation, and the Introduction of New, Large, Automated Platforms
Rapid Point-of-Care Testing with Single Pathogen Infectious Disease Tests
Looking to the East